Macular telangiectasia is a neurodegenerative disease of the macula that affects both eyes and causes loss of central vision. Type 2 is the most common, although its prevalence in the population is 0.12%.
Macular telangiectasia type 2
Macular telangiectasia type 2 is a rare retinal disease that is not yet well characterized. It involves the dilation of the retinal capillaries in the macula, which can be primary or secondary, associated with other vascular pathologies.
This condition is more common in middle-aged adults, and both men and women are equally affected. It is a relatively unknown disease, although it has been associated with some conditions such as diabetes or hypertension.
Symptoms
In the early stages of the disease, no symptoms are present. As it progresses, visual problems such as blurred vision, distorted vision, and loss of central vision may occur. Generally, peripheral vision is not affected, and it does not cause total blindness. This loss is progressive and can be experienced over the years.
Prevention
The causes that lead to the appearance of macular telangiectasia type 2 are unknown, and therefore no preventive measures have been identified for its occurrence.
Currently, the disease has a relatively good prognosis as there are treatments that significantly improve vision in affected individuals. Thus, since it initially presents no symptoms, early diagnosis of the disease can greatly help limit its progression.
Additionally, it may sometimes be associated with other conditions such as diabetes or hypertension, so good control of these can reduce the risk in these patients.
Number of observed variants
13.5 million variants
Number of risk loci
10 loci
Genes analyzed
Bibliography
Bayón-Porras R.M. et al. Telangiectasias maculares idiopáticas de tipo 2: prevalencia en nuestra área y estudio morfométrico y fenotípico. Archivos de la Sociedad Española de Oftalmología. 2018;93(3): 105-112.
Macular telangiectasia. American Academy of Ophthalmology [Apr 2023].
Bonelli R, Jackson VE, Prasad A, et al. Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder.
